2013

• Topp, L., Islam, M., Day, C. (2013), Relative efficacy of cash versus vouchers in engaging opioid substitution treatment clients in survey-based research. Journal of Medical Ethics. 39(4), 253-256. [Abstract]
• Islam, M., Day, C., Conigrave, K., Topp, L. (2013), Self-perceived problem with alcohol use among opioid substitution treatment clients. Addictive Behaviors. 38(4), 2018-2021. [Abstract]
• Islam, M., Shanahan, M., Topp, L., Conigrave, K., White, A., Day, C. (2013), The cost of providing primary health-care services from a needle and syringe program: A case study. Drug and Alcohol Review. 32(3), 312-319. [Abstract]
• Islam, M., Topp, L., Conigrave, K., Day, C. (2013), Opioid substitution therapy clients' preferences for targeted versus general primary health-care outlets. Drug and Alcohol Review. 32(2), 211-214. [Abstract]

2012

• Islam, M., Topp, L., Conigrave, K., White, A., Reid, S., Grummett, S., Haber, P., Day, C. (2012), Linkage into specialist hepatitis C treatment services of injecting drug users attending a needle syringe program-based primary healthcare centre. Journal of Substance Abuse Treatment. 43(4), 440-445. [Abstract]
• Deacon, R., Topp, L., Wand, H., Day, C., Rodgers, C., Haber, P., van Beek, I., Maher, L. (2012), Correlates of Susceptibility to Hepatitis B among People Who Inject Drugs in Sydney, Australia. Journal of Urban Health. 89(5), 769-778. [Abstract]
• Day, C., Demirkol, A., Tynan, M., Curry, K., Hines, S., Lintzeris, N., Haber, P. (2012), Individual versus team-based case-management for clients of opioid treatment services: An initial evaluation of what clients prefer. Drug and Alcohol Review. 31(4), 499-506. [Abstract]
• Alavi, M., Grebely, J., Matthews, G., Petoumenos, K., Yeung, B., Day, C., Lloyd, A., Van Beek, I., Kaldor, J., Hellard, M., Dore, G., Haber, P. (2012), Impact of pegylated interferon alfa-2a treatment on mental health during recent hepatitis C virus infection. Journal of Gastroenterology and Hepatology. 27(5), 957-965. [Abstract]
• Islam, M., Topp, L., Conigrave, K., van Beek, I., Maher, L., White, A., Rodgers, C., Day, C. (2012), The reliability of sensitive information provided by injecting drug users in a clinical setting: Clinician-administered versus audio computer-assisted self-interviewing (ACASI). AIDS Care. 24(12), 1496-1503. [Abstract]
• Islam, M., Topp, L., Day, C., Dawson, A., Conigrave, K. (2012), The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: A narrative synthesis of literature. International Journal of Drug Policy. 23(2), 94-102. [Abstract]
• Mofizul Islam, M., Topp, L., Day, C., Dawson, A., Conigrave, K. (2012), Primary healthcare outlets that target injecting drug users: opportunity to make services accessible and acceptable to the target group. The International Journal on Drug Policy. 23(2), 109-110. [Abstract]

2011

• Day, C., Topp, L. (2011), Commentary on Turner et al. (2011): Significant global scale-up of harm reduction interventions and pragmatic research approaches needed to prevent hepatitis C transmission. Addiction. 106(11), 1989-1990. [Abstract]
• Islam, M., Grummett, S., White, A., Reid, S., Day, C., Haber, P. (2011), A primary healthcare clinic in a needle syringe program may contribute to HIV prevention by early detection of incident HIV in an injecting drug user. Australian and New Zealand Journal of Public Health. , 294-295. [Abstract]
• Topp, L., Day, C., Iversen, J., Wand, H., Maher, L. (2011), Fifteen years of HIV surveillance among people who inject drugs: the australian needle and syringe program survey 1995-2009. AIDS (London, England). 25(6), 835-42. [Abstract]
• Day, C., Islam, M., White, A., Reid, S., Hayes, S., Haber, P. (2011), Development of a nurse-led primary healthcare service for injecting drug users in inner-city Sydney. Australian Journal of Primary Health. 17(1), 10-15. [Abstract]
• Chaar, B., Hanrahan, J., Day, C. (2011), Provision of Opioid Substitution Therapy Services in Australian Pharmacies. Australasian Medical Journal. 4:4, 210-216.

2010

• Sanson-Fisher, R., Brand, M., Shakeshaft, A., Haber, P., Day, C., Conigrave, K., Mattick, R., Lintzeris, N., Teesson, M. (2010), Forming a national multicentre collaboration to conduct clinical trials: increasing high-quality research in the drug and alcohol field. Drug and Alcohol Review. 29(5), 469-474. [Abstract]
• Day, C., White, B., Dore, G., van Beek, I., Rodgers, C., Cunningham, P., Wodak, A., Maher, L. (2010), Hepatitis B virus among injecting drug users in Sydney, Australia: prevalence, vaccination and knowledge of status. Drug and Alcohol Dependence. 108(1-2), 134-137. [Abstract]
• Islam, M., Day, C., Conigrave, K. (2010), Harm reduction healthcare: From an alternative to the mainstream platform?. The International journal on drug policy. 21(2), 131-3. [Abstract]
• Dunn, M., Day, C., Bruno, R., Degenhardt, L., Campbell, G. (2010), Sexual and injecting risk behaviours among regular ecstasy users. Addictive Behaviors. 35(2), 157-160. [Abstract]
• Ramasamy, P., Lintzeris, N., Sutton, Y., Taylor, H., Day, C., Haber, P. (2010), The outcome of a rapid hepatitis B vaccination programme in a methadone treatment clinic. Addiction. 105(2), 329-334. [Abstract]

2009

• Coupland, H., Day, C., Levy, M., Maher, L. (2009), Promoting equitable access to hepatitis C treatment for Indo-Chinese injecting drug users. Health Promotion Journal of Australia. 20(3), 234-240. [Abstract]
• Doab, A., Topp, L., Day, C., Dore, G., Maher, L. (2009), Clinical trial literacy among injecting drug users in Sydney, Australia: A pilot study. Contemporary clinical trials. 30(5), 431-5. [Abstract]
• Topp, L., Day, C., Dore, G., Maher, L. (2009), Poor criterion validity of self-reported hepatitis B infection and vaccination status among injecting drug users: A review. Drug and Alcohol Review. 28(6), 669-675. [Abstract]
• Day, C., Haber, P. (2009), Managing drug dependence in people with hepatitis C. In: Hepatitis C: An Expanding Perspective. (pp.288-307).Australia: IP Communications.

2008

• O'Brien, S., Day, C., Black, E., Dolan, K. (2008), Injecting drug users' understanding of hepatitis C. Addictive behaviors. 33(12), 1602-5. [Abstract]
• Day, C., Topp, L., Iversen, J., Maher, L., Nsps, O. (2008), Blood-borne virus prevalence and risk among steroid injectors: Results from the Australian Needle and Syringe Program Survey. Drug and alcohol review. 27(5), 559-61. [Abstract]
• Topp, L., Iversen, J., Wand, H., Day, C., Kaldor, J., Maher, L. (2008), Representativeness of injecting drug users who participate in HIV surveillance: results from Australia's Needle and Syringe Program Survey. Journal of Acquired Immune Deficiency Syndromes. 47(5), 632-638. [Abstract]
• White, B., Day, C., Thein, H., Doab, A., Bates, A., Holden, J., van Beek, I., Maher, L. (2008), Acceptability of hepatitis C virus testing methods among injecting drug users. Drug and Alcohol Review. 27(6), 666-670. [Abstract]
• Day, C., White, B., Thein, H., Doab, A., Dore, G., Bates, A., Holden, J., Maher, L. (2008), Experience of hepatitis C testing among injecting drug users in Sydney, Australia. AIDS Care. 20(1), 116-123. [Abstract]
• Conroy, E., Day, C., Kimber, J., Dolan, K. (2008), An examination of the quality of life among rural and outer metropolitan injecting drug users in NSW, Australia. Addiction Research and Theory. 16, 607-617.

2007

• White, B., Day, C., Maher, L. (2007), Self reported risk behaviour among injecting drug users: self versus assisted questionnaire completion. AIDS care. 19(3), 441-7. [Abstract]